TCAF vs BOUT

ATCAF

BBOUT

Measures won5–0TCAF wins · of 6 · 5Y

$10,000 · 5Y$17,787RECS · BOUT $10,987

Lowest cost0.15%RECS · $15 on $10k

Most income1.04%RECS · $104 on $10k

Smallest drop−8.8%RECS · worst fall in 1Y

Held in common0.0%TCAF and BOUT

TCAF

BOUT

T. Rowe Capital Appreciation Equity ETF · $7.9BCapForce IBD Breakout Opportunities ETF · $14M

+20.3%3 years · per year$17,395 · $13,577+10.7%

[…]5 years · per year[…] · $10,987+1.9%

0.31%Expense ratio$31 · $80 on $10k · lower wins0.80%

0.45%12-mo yield$45 · $32 on $10k0.32%

−10.8%Worst dropSmaller wins−20.8%

13.1%VolatilityLower wins22.4%

5–0TCAF wins

$10,000 · 5 yearsAll four, one scale

Shared top holdingsTCAF · BOUT

They share no top holdings, or holdings aren’t on file […]

Held in common0.0%

End-of-day Nov 6, 2026 · $10,000 5 years ago, dividends reinvested · ● winner of the row · each row scaled to the bigger of the two

All Four

5Y4 funds

#
1	RECS	Columbia Research Enhanced Core ETFRead Desk	0.15%	1.04%	+0.1%	+7.3%	+9.1%	+22.2%	+12.2%	−8.8%	$6.0B
2	BBOUT	CapForce IBD Breakout Opportunities ETFRead Desk	0.80%	0.32%	−0.9%	+6.7%	+4.6%	+10.7%	+1.9%	−20.8%	$14M
3	ATCAF	T. Rowe Capital Appreciation Equity ETFRead Desk	0.31%	0.45%	+0.8%	+10.6%	+10.3%	+20.3%	new	−10.8%	$7.9B
4	SEQ	Sequoia ETFRead Desk	0.99%	0.00%	−0.5%	new	new	new	new	[…]	$6.8B

End-of-day Nov 6, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus

All Four

5Y4 funds

#
1	RECS	Columbia Research Enhanced Core ETFRead Desk	0.15%	1.04%	+0.1%	+7.3%	+9.1%	+22.2%	+12.2%	−8.8%	$6.0B
2	BBOUT	CapForce IBD Breakout Opportunities ETFRead Desk	0.80%	0.32%	−0.9%	+6.7%	+4.6%	+10.7%	+1.9%	−20.8%	$14M
3	ATCAF	T. Rowe Capital Appreciation Equity ETFRead Desk	0.31%	0.45%	+0.8%	+10.6%	+10.3%	+20.3%	new	−10.8%	$7.9B
4	SEQ	Sequoia ETFRead Desk	0.99%	0.00%	−0.5%	new	new	new	new	[…]	$6.8B

End-of-day Nov 6, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus

Cards for this view

TCAF vs BOUT

TCAF

T. Rowe Capital Appreciation Equity

[…]

BOUT

CapForce IBD Breakout Opportunities

$10,987

MeasureTCAFBOUT

Fee0.31%0.80%

Cost on $10k a year$31$80

Yield0.45%0.32%

5 years, per year[…]+1.9%

3 years, per year+20.3%+10.7%

Worst drop · 1Y−10.8%−20.8%

Volatility · 1Y13.1%22.4%

5–0measures won
TCAF first

0.0%

holdings shared

Nov 6, 2026 · $10,000 five years ago, dividends reinvested

SCHD vs VIG

YTD

SchwabSCHD

+31.4%

VIGVanguard

+12.1%

+31.4%Year to date+12.1%

3.0%Yield1.5%

$120BAssets$109B

2–0SCHD wins

End-of-day Nov 6, 2026

JEPQ vs JEPI

YTD

J.P. MorganJEPQ

+3.2%

JEPIJ.P. Morgan

+5.3%

+3.2%Year to date+5.3%

12.8%Yield8.1%

$40.7BAssets$45.2B

1–1level

End-of-day Nov 6, 2026

SPYM vs SPY

YTD

SPDRSPYM

+8.8%

SPYSPDR

+8.7%

+8.8%Year to date+8.7%

1.1%Yield1.0%

$178BAssets$778B

2–0SPYM wins

End-of-day Nov 6, 2026

Overlap: TCAF, BOUT, RECS, SEQ

Today

1.6%most shared, TCAF and RECS

TCAFBOUTRECSSEQ

TCAF—0.0%1.6%[…]

BOUT0.0%—0.4%[…]

RECS1.6%0.4%—[…]

SEQ[…][…][…]—

End-of-day Nov 6, 2026 · share held in common · outlined: the pair in versus

Income After Fees on $10,000

$89most kept, RECS

RECS$104 − $15 = $89

TCAF$45 − $31 = $14

BOUT$32 − $80 = −$48

SEQ$0 − $99 = −$99

KeptFee

End-of-day Nov 6, 2026 · yield in dollars minus the fee